- Home
- LPTH vs XGN Comparison
LPTH vs XGN Comparison
Compare LPTH & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTH
- XGN
- Stock Information
- Founded
- LPTH 1985
- XGN 2002
- Country
- LPTH United States
- XGN United States
- Employees
- LPTH N/A
- XGN N/A
- Industry
- LPTH Semiconductors
- XGN Medical Specialities
- Sector
- LPTH Technology
- XGN Health Care
- Exchange
- LPTH Nasdaq
- XGN Nasdaq
- Market Cap
- LPTH 229.5M
- XGN 210.4M
- IPO Year
- LPTH 1996
- XGN 2019
- Fundamental
- Price
- LPTH $8.87
- XGN $10.88
- Analyst Decision
- LPTH Strong Buy
- XGN Strong Buy
- Analyst Count
- LPTH 3
- XGN 5
- Target Price
- LPTH $6.83
- XGN $12.40
- AVG Volume (30 Days)
- LPTH 1.9M
- XGN 248.4K
- Earning Date
- LPTH 11-06-2025
- XGN 11-11-2025
- Dividend Yield
- LPTH N/A
- XGN N/A
- EPS Growth
- LPTH N/A
- XGN N/A
- EPS
- LPTH N/A
- XGN N/A
- Revenue
- LPTH $37,202,630.00
- XGN $58,862,000.00
- Revenue This Year
- LPTH $50.36
- XGN $22.28
- Revenue Next Year
- LPTH $7.77
- XGN $14.03
- P/E Ratio
- LPTH N/A
- XGN N/A
- Revenue Growth
- LPTH 17.26
- XGN 3.89
- 52 Week Low
- LPTH $1.40
- XGN $2.38
- 52 Week High
- LPTH $9.34
- XGN $11.17
- Technical
- Relative Strength Index (RSI)
- LPTH 69.28
- XGN 63.84
- Support Level
- LPTH $6.47
- XGN $9.30
- Resistance Level
- LPTH $8.40
- XGN $11.11
- Average True Range (ATR)
- LPTH 0.70
- XGN 0.43
- MACD
- LPTH 0.06
- XGN 0.04
- Stochastic Oscillator
- LPTH 85.46
- XGN 84.17
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc is a manufacturer, distributor, and integrator of proprietary optical components and assemblies. It is also engaged in the research and development for optical solutions for the traditional optics markets and communications markets. The company's business based on the following product groups: precision molded optics, specialty products, and infrared products. It currently serves the following major markets, distribution and catalog, laser, industrial, instrumentation, telecommunications, and defense.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.